Detoxification From the Lipid Tract
Conditions: COVID-19 Vaccine Adverse Reaction Interventions: Device: electroencephalogram biofeedback; Device: electrical brain stimulation; Device: ultra-low frequency transcranial magnetic stimulation; Drug: Sertraline Hydrochloride; Drug: Clonazepam; Drug: Alprazolam; Drug: Metoprolol; Drug: Olanzapine; Drug: Pravastatin Sodium 20 MG; Drug: Sacubitril Valsartan Sodium Hydrate Sponsors: Pachankis, Yang I., M.D.; First Affiliated Hospital of Chongqing Medical University Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 10, 2024 Category: Research Source Type: clinical trials
Survival With Olanzapine in Patients With Locally Advanced or Metastatic Upper Gastrointestinal and Lung Cancer
Conditions: Advanced Cancer; Olanzapine; Progression Free Survival Interventions: Drug: Olanzapine 2.5 MG; Drug: Standard anti-tumor treatment; Dietary Supplement: Nutritional advice Sponsors: Qinghai Red Cross Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 29, 2024 Category: Research Source Type: clinical trials
NEPA Combined With Olanzapine, Dexamethasone-sparing for the Effect of CINV in Patients Receiving HEC Regimens
Conditions: Chemotherapy-induced Nausea and Vomiting; Highly Emetogenic Chemotherapy Interventions: Drug: Netupitant / Palonosetron Oral Capsule [Akynzeo]; Drug: Olanzapine; Drug: Dexamethasone Oral Sponsors: Fudan University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 26, 2024 Category: Research Source Type: clinical trials
Open-label Trial Characterizing the PK of 3 SC Olanzapine Extended-release Formulations in Participants With Schizophrenia/Schizoaffective Disorder.
Conditions: Schizophrenia, Schizoaffective Disorder Interventions: Drug: Olanzapine Extended Release; Drug: Olanzapine Sponsors: Teva Branded Pharmaceutical Products R&D, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 19, 2024 Category: Research Source Type: clinical trials
An Open-Label Trial to Assess the Comparative Bioavailability of TV-44749 to Oral Olanzapine in Participants With Schizophrenia
Conditions: Schizophrenia Interventions: Drug: TV-44749; Drug: Oral olanzapine Sponsors: Teva Branded Pharmaceutical Products R&D, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 18, 2024 Category: Research Source Type: clinical trials
Electroacupuncture Plus Antiemetic Therapy for Chemotherapy-Induced Nausea and Vomiting in Patients With Breast Cancer
Conditions: Electroacupuncture; Olanzapine-contained Four-drug Antiemetic; Nausea and Vomiting Interventions: Device: Electroacupuncture; Drug: Antiemetic Therapy; Device: Sham electroacupuncture; Drug: Antiemetic Therapy Sponsors: Feixue Song Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 18, 2024 Category: Research Source Type: clinical trials
Efficacy of Olanzapine on Weight Gain in Women With Advanced Stage Gynecologic Cancer Receiving Paclitaxel and Carboplatin Combination Chemotherapy : a Double Blind, Placebo-controlled Randomized Trial
Conditions: Weight Gain Interventions: Drug: Olanzapine 5 MG Sponsors: Rajavithi Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 1, 2024 Category: Research Source Type: clinical trials
Safety, Tolerability, and Pharmacokinetic Study of TV-44749 in Chinese Patients With Schizophrenia
Conditions: Schizophrenia Interventions: Drug: TV-44749; Drug: Oral Olanzapine Sponsors: Teva Branded Pharmaceutical Products R&D, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 12, 2024 Category: Research Source Type: clinical trials
Effects of Antipsychotics on Brain Insulin Action in Females
Conditions: Insulin Resistance; Menstrual Cycle; Type 2 Diabetes; Antipsychotics Interventions: Drug: Olanzapine 2.5Mg Oral Tablet; Drug: Placebo; Drug: Insulin Lispro 100 UNT/ML; Drug: Saline Sponsors: Centre for Addiction and Mental Health Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 9, 2024 Category: Research Source Type: clinical trials
Synergistic Effect of Vitamin E & D in Reducing Risk of Effects Associated With Atypical Anti-psychotics
Conditions: Antipsychotics and Neuroleptics Toxicity Interventions: Drug: Risperidone; Drug: Olanzapine; Drug: Quetiapine; Drug: Risperidone and Vitamin D and Vitamin E; Drug: Olanzapine and Vitamin D and Vitamin E; Drug: Quetiapine and Vitamin D and Vitamin E Sponsors: Dr Rabia Arshad Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 11, 2024 Category: Research Source Type: clinical trials
Electroacupuncture for the Prevention of Chemotherapy-induced Nausea and Vomiting in Patients With Breast Cancer
Conditions: Electroacupuncture; Olanzapine-contained Four-drug Antiemetic; Nausea and Vomiting Interventions: Device: Electroacupuncture; Drug: Standard antiemetic treatment; Device: Sham electroacupuncture; Drug: Standard antiemetic treatment Sponsors: Jiuda Zhao Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 10, 2024 Category: Research Source Type: clinical trials
Effect of Olanzapine on Opioid Craving and Misuse Among Patients Receiving Opioids for Cancer-related Pain: A Pilot Double-Blind, Randomized Control Trial
Conditions: Misuse, Opioid Interventions: Drug: Olanzapine; Drug: Olanzapine; Drug: Placebo Sponsors: M.D. Anderson Cancer Center Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 10, 2024 Category: Research Source Type: clinical trials
Characterizing Response to Antipsychotics in Schizophrenia
Conditions: Schizophrenia; Schizoaffective Disorder Interventions: Drug: Olanzapine; Drug: Clozapine Sponsors: The Royal Ottawa Mental Health Centre; The Royal ' s Institute of Mental Health Research Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 6, 2023 Category: Research Source Type: clinical trials
Psychopharmacological Treatment of Emotional Distress
Conditions: Suicide Crisis Syndrome; Psychological Distress Interventions: Drug: Clonazepam; Drug: Olanzapine; Drug: Buprenorphine; Drug: Treatment As Usual Sponsors: Icahn School of Medicine at Mount Sinai Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 15, 2023 Category: Research Source Type: clinical trials
The Characteristics of Treatment Resistant Schizophrenia From the Illness Onset
Conditions: Treatment-resistant Schizophrenia Interventions: Drug: risperidone, olanzapine, aripiprazole Sponsors: Peking University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 13, 2023 Category: Research Source Type: clinical trials
